← Leaderboards
Laura K Bachrach
Stanford University
$17,988
Attributed
$17,988
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5K · FY2005–08$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$17,988 · 4
By mechanism
M01$17,988 · 4
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Vinod Menon$45,459,463
- Kari C. Nadeau$30,132,783
- Allan L Reiss$43,607,755
- Harry Bernard Greenberg$91,083,131
- Thomas N Robinson$40,790,008
Others in their field
Top investigators on “Bone Density”
- Richard A Gibbs · Baylor College Of Medicine$49,965,365
- Steven R Cummings · University Of California San Francisco$45,557,505
- Peter J. Snyder · University Of Pennsylvania$37,887,894
- Douglas P. Kiel · Hebrew Rehabilitation Center For Aged$31,628,442
- Eric S. Orwoll · Oregon Health And Science University$27,305,691
- Hong-Wen Deng · Father Flanagan'S Boys'Home$24,036,296
Research focus
Bone DensityInflammatory Bowel DiseasesAlendronateRheumatologic DisorderChronicSourceSteroid TherapyUnited States National Institutes Of HealthVertebral ColumnBisphosphonateClinical TrialsRandomized Placebo Controlled TrialFundingGlucocorticoidsGrantBone And BonesInstitutionChildOralChildhoodComputer Retrieval Of Information On Scientific Projects DatabaseResearch PersonnelResourcesHuman Therapy Evaluation
Grant awards (5)
CLINICAL TRIAL: ALENDRONATE FOR CHILDHOOD GLUCOCORTICOID-ASSOCIATED OSTEOPENIA A$114
M01 · FY2008 · RR · contact PI
CHILDHOOD AND ADOLESCENT GLUCOCORTICOID OSTEOPENIA AND OSTEOPOROSIS$2,340
M01 · FY2007 · RR · contact PI
CHILDHOOD AND ADOLESCENT GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS$4,003
M01 · FY2006 · RR · contact PI
CHILDHOOD AND ADOLESCENT GLUCOCORTICOID-ASSOCIATED OSTEOPENIA AND OSTEOPOROSIS$5,012
M01 · FY2005 · RR
Double Blind Controlled Trial of Alendronate$6,519
M01 · FY2004 · RR